Artificial Intelligence Tools in the Global Deployment of Vaccines and Alternatives Modes of Immunotherapy for the Evolving SARS-CoV-2 Variants, From the UK Perspectivess

Abstract

This commentary is focused on a working title: “The story of a different year, with enormous challenges imposed by CoV-2 strains” and how we have responded to the way back to normality, where the use of newer artificial intelligence tools become extremely useful in the procedurals, patterns and big data analyses of the “new generation of vaccines and convalescent plasma therapy for management of CoV-2”. The goal is to highlights the current status of deployment of vaccines, from the UK perspectives, in two specific areas.